PoSt-market Assessment on Safety and Performance of J-sHAPed xFINE Lead

NCT05440071 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2022-06-30

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the safety and the electrical performances of the right atrial J-shape (JX model) XFINE endovascular passive lead at 3 months post implant.

Conditions

  • Bradycardia

Interventions

DEVICE

JX- XFINE lead

Pacemaker subjects implanted with one JX - XFINE passive pacing lead

Sponsors & Collaborators

  • MicroPort CRM

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2023-10-31
Completion
2024-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05440071 on ClinicalTrials.gov